Bringing innovative pharmaceutical products to market requires overcoming complex challenges across development, clinical trials and manufacturing. Disconnects between formulation, analytical, regulatory and manufacturing activities can disrupt timelines, increase risk and delay market entry.
We provide integrated CDMO services that span the full pharmaceutical product life cycle – from early-stage formulation and analytical development through clinical supply and commercial manufacture. Our MHRA and FDA-approved facility, scientific expertise and integrated quality systems support new chemical entities, biologics and live biotherapeutic products for global markets, helping you progress with regulatory confidence at every stage.
Looking for something specific?
Search within CDMO Solutions
Quay House, 28 Parkway Deeside Ind. Park,
CH5 2NS,
Flintshire, Wales, United Kingdom






